Perry aide Iwamasa to be sentenced in ketamine case

What's happened

Kenneth Iwamasa, 60, faces sentencing in a Los Angeles federal court for conspiracy to distribute ketamine resulting in death. Prosecutors seek three years and five months in prison, arguing Iwamasa helped Perry obtain ketamine and assisted in the drug’s distribution ahead of Perry’s death.

What's behind the headline?

Key takeaways

The sentencing reflects the leverage of a cooperating witness in federal drug prosecutions, potentially shaping outcomes for co-defendants.
The narrative highlights a broader issue of off-label and illicit ketamine use among public figures, raising questions about oversight and accountability for those close to high‑profile individuals.
Expect defense and prosecution filings to emphasize vulnerability and coercion, while family letters underscore perceived culpability and loss.

What this means for readers

The sentence will likely set a benchmark for similar cases involving recovery‑oriented but morally charged celebrity scandals.
The court's handling could influence ongoing investigations into ketamine distribution networks connected to Perry’s death.

How we got here

The case centers on actor Matthew Perry’s 2023 death, linked to ketamine obtained and administered by his longtime associate Iwamasa. Iwamasa pled guilty in August 2024 and has cooperated with prosecutors, offering details of off‑the‑books ketamine procurement from doctors and street sources.

Our analysis

The Associated Press (NY Post), The Independent provide the core chronology of Kenneth Iwamasa’s role, plea, and sentencing. The reporting underscores the chain of ketamine sourcing from doctors and dealers, and the family statements accompanying the court filings.

Go deeper

What sentence will the judge hand down today?
How will Iwamasa’s testimony influence the other defendants?
What does this case suggest about ketamine use and oversight around celebrities?